Atlas Trials

Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration

Clinical trial NCT02121353 · COMPLETED

Trial details

NCT number
NCT02121353
Sponsor
Pfenex, Inc
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Age Related Macular Degeneration (AMD)
Start date
2013-11-01
Primary completion
2016-01-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.